Oncoinvent ASA (KLDVK) — Capital Reinvestment Ratio
Latest as of December 2025:
0.58x
Oncoinvent ASA (KLDVK) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Nkr3.64 Million) in capital expenditures (Nkr2.12 Million). See cash generation quality of Oncoinvent ASA to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.58x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr3.64 Million
NOK
Capital Expenditures
Nkr2.12 Million
NOK
Data as of
Dec 2025
Most recent filing
Oncoinvent ASA Capital Reinvestment Ratio (2021–2022)
This chart tracks Oncoinvent ASA's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Oncoinvent ASA (2021–2022)
Year-by-year Capital Reinvestment Ratio for Oncoinvent ASA from 2021 to 2022. For live market cap and broader valuation context, see Oncoinvent ASA market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 32.49x | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr130.66K | Nkr30.88 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow